Literature DB >> 10602345

Functional studies in atrium overexpressing A1-adenosine receptors.

J Neumann1, U Vahlensieck, P Boknik, B Linck, H Lüss, F U Müller, G P Matherne, W Schmitz.   

Abstract

1. Adenosine and the A1-adenosine receptor agonist R-PIA, exerted a negative inotropic effect in isolated, electrically driven left atria of wild-type mice. 2. In left atria of mice overexpressing the A1-adenosine receptor, adenosine and R-PIA exerted a positive inotropic effect. 3. The positive inotropic effect of adenosine and R-PIA in transgenic atria could be blocked by the A1-adenosine receptor antagonist DPCPX. 4. In the presence of isoprenaline, adenosine exerted a negative inotropic effect in wild-type atria but a positive inotropic effect in atria from A1-adenosine receptor overexpressing mice. 5. The rate of beating in right atria was lower in mice overexpressing A1-adenosine receptors compared with wild-type. 6. Adenosine exerted comparable negative chronotropic effects in right atria from both A1-adenosine receptor overexpressing and wild-type mice. 7. A1-adenosine receptor overexpression in the mouse heart can reverse the inotropic but not the chronotropic effects of adenosine, implying different receptor-effector coupling mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602345      PMCID: PMC1571796          DOI: 10.1038/sj.bjp.0702963

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly selective adenosine receptor antagonist, on force of contraction in guinea-pig atrial and ventricular cardiac preparations.

Authors:  H von der Leyen; W Schmitz; H Scholz; J Scholz; M J Lohse; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

Review 2.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.

Authors:  J C Shryock; L Belardinelli
Journal:  Am J Cardiol       Date:  1997-06-19       Impact factor: 2.778

3.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

4.  On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins.

Authors:  Y Kurachi; T Nakajima; T Sugimoto
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

5.  Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.

Authors:  G P Matherne; J Linden; A M Byford; N S Gauthier; J P Headrick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors.

Authors:  N S Gauthier; J P Headrick; G P Matherne
Journal:  J Mol Cell Cardiol       Date:  1998-01       Impact factor: 5.000

7.  Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.

Authors:  J Neumann; P Boknik; A A DePaoli-Roach; L J Field; H A Rockman; Y M Kobayashi; J S Kelley; L R Jones
Journal:  J Mol Cell Cardiol       Date:  1998-10       Impact factor: 5.000

8.  Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.

Authors:  M Böhm; R Brückner; I Hackbarth; B Haubitz; R Linhart; W Meyer; B Schmidt; W Schmitz; H Scholz
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

9.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Inhibition of the effects of adenosine on force of contraction and the slow calcium inward current by pertussis toxin is associated with myocardial lesions.

Authors:  M Böhm; R Brückner; H Schäfer; W Schmitz; H Scholz
Journal:  Cardiovasc Res       Date:  1988-02       Impact factor: 10.787

View more
  6 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

Review 2.  Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man.

Authors:  Arthur M Feldman; Ellina Cheksis-Feiner; Eman Hamad; Tung Chan
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

3.  Genetic disruption of G proteins, G(i2)alpha or G(o)alpha, does not abolish inotropic and chronotropic effects of stimulating muscarinic cholinoceptors in atrium.

Authors:  P Boknik; S Grote-Wessels; G Barteska; M Jiang; F U Müller; W Schmitz; J Neumann; L Birnbaumer
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

4.  A positive inotropic effect of adenosine in cardiac preparations of right atria from diseased human hearts.

Authors:  Ulrich Gergs; Peter Boknik; Wilhelm Schmitz; Andreas Simm; Rolf-Edgar Silber; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-27       Impact factor: 3.000

5.  Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A(1)-adenosine receptors.

Authors:  Joachim Neumann; Peter Boknik; G Paul Matherne; Amy Lankford; Wilhelm Schmitz
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

6.  Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.

Authors:  Bruno Bragança; Nádia Oliveira-Monteiro; Fátima Ferreirinha; Pedro A Lima; Miguel Faria; Ana P Fontes-Sousa; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2016-03-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.